Analysts See $0.03 EPS for DexCom, Inc. (DXCM); 3 Analysts Bullish Fossil Group, Inc. (FOSL)

February 15, 2018 - By Migdalia James

Analysts expect DexCom, Inc. (NASDAQ:DXCM) to report $0.03 EPS on February, 27.They anticipate $0.12 EPS change or 133.33% from last quarter’s $-0.09 EPS. DXCM’s profit would be $2.61 million giving it 464.50 P/E if the $0.03 EPS is correct. After having $-0.03 EPS previously, DexCom, Inc.’s analysts see -200.00% EPS growth. The stock increased 1.96% or $1.07 during the last trading session, reaching $55.74. About 922,287 shares traded. DexCom, Inc. (NASDAQ:DXCM) has risen 9.41% since February 15, 2017 and is uptrending. It has underperformed by 7.29% the S&P500.

Among 17 analysts covering Fossil (NASDAQ:FOSL), 3 have Buy rating, 6 Sell and 8 Hold. Therefore 18% are positive. Fossil had 56 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Fossil Group, Inc. (NASDAQ:FOSL) earned “Hold” rating by Jefferies on Wednesday, August 9. As per Wednesday, August 9, the company rating was maintained by Bank of America. Oppenheimer maintained Fossil Group, Inc. (NASDAQ:FOSL) on Tuesday, August 8 with “Hold” rating. S&P Research maintained Fossil Group, Inc. (NASDAQ:FOSL) rating on Thursday, August 13. S&P Research has “Buy” rating and $70 target. The firm earned “Hold” rating on Thursday, August 10 by Piper Jaffray. The stock of Fossil Group, Inc. (NASDAQ:FOSL) earned “Overweight” rating by KeyBanc Capital Markets on Wednesday, November 8. Jefferies maintained the stock with “Hold” rating in Wednesday, February 14 report. Telsey Advisory Group maintained it with “Market Perform” rating and $23 target in Wednesday, February 15 report. The firm earned “Sell” rating on Friday, December 18 by Goldman Sachs. Jefferies maintained Fossil Group, Inc. (NASDAQ:FOSL) on Tuesday, July 4 with “Hold” rating. See Fossil Group, Inc. (NASDAQ:FOSL) latest ratings:

14/02/2018 Broker: Jefferies Rating: Hold New Target: $16.0 Maintain
14/02/2018 Broker: Buckingham Research Old Rating: Neutral New Rating: Underperform Old Target: $5 New Target: $8 Maintain
14/02/2018 Broker: KeyBanc Capital Markets Old Rating: Overweight New Rating: Overweight Old Target: $15 New Target: $25 Maintain
08/11/2017 Broker: Bank of America Rating: Underperform Old Target: $7 New Target: $4 Maintain
08/11/2017 Broker: Buckingham Research Rating: Neutral Old Target: $9 New Target: $5 Maintain
08/11/2017 Broker: KeyBanc Capital Markets Rating: Overweight Old Target: $24 New Target: $15 Maintain
11/10/2017 Broker: Piper Jaffray Rating: Hold New Target: $10.0 Maintain
14/09/2017 Broker: Jefferies Rating: Hold New Target: $13.0 Maintain

Investors sentiment decreased to 0.97 in 2017 Q3. Its down 0.39, from 1.36 in 2017Q2. It fall, as 59 investors sold DexCom, Inc. shares while 69 reduced holdings. 31 funds opened positions while 93 raised stakes. 98.30 million shares or 1.76% more from 96.59 million shares in 2017Q2 were reported. Ftb Advisors holds 0% or 280 shares in its portfolio. Jpmorgan Chase And invested 0.02% in DexCom, Inc. (NASDAQ:DXCM). San Francisco Sentry Group (Ca) owns 50 shares or 0% of their US portfolio. 125,283 were accumulated by Nuveen Asset Management Lc. First Mercantile Trust Co reported 0.04% stake. Moreover, Eulav Asset Mgmt has 0.25% invested in DexCom, Inc. (NASDAQ:DXCM). 14,235 were reported by Credit Agricole S A. Dafna Limited Liability Company accumulated 1.75% or 57,500 shares. Suntrust Banks Inc owns 10,969 shares or 0% of their US portfolio. Pictet Asset Ltd holds 0.04% or 306,769 shares in its portfolio. Tci Wealth holds 0% or 9 shares in its portfolio. Comml Bank Of Mellon invested in 985,789 shares or 0.01% of the stock. Parallax Volatility Advisers Limited Partnership invested in 3,495 shares or 0% of the stock. Tocqueville Asset Mngmt L P stated it has 0% in DexCom, Inc. (NASDAQ:DXCM). Bnp Paribas Arbitrage Sa invested in 0% or 22,094 shares.

Since August 23, 2017, it had 0 insider purchases, and 11 selling transactions for $2.57 million activity. Shares for $416,044 were sold by SAYER KEVIN R. 3,244 DexCom, Inc. (NASDAQ:DXCM) shares with value of $234,441 were sold by Balo Andrew K. $101,219 worth of DexCom, Inc. (NASDAQ:DXCM) was sold by Pacelli Steven Robert on Monday, September 25. 1,635 shares were sold by DOUBLEDAY RICHARD, worth $89,384 on Tuesday, January 23. The insider GREGG TERRANCE H sold 10,000 shares worth $568,588.

Among 23 analysts covering Dexcom (NASDAQ:DXCM), 16 have Buy rating, 1 Sell and 6 Hold. Therefore 70% are positive. Dexcom had 63 analyst reports since August 6, 2015 according to SRatingsIntel. The rating was maintained by BMO Capital Markets on Wednesday, November 1 with “Buy”. The stock of DexCom, Inc. (NASDAQ:DXCM) earned “Buy” rating by Canaccord Genuity on Thursday, November 2. The stock of DexCom, Inc. (NASDAQ:DXCM) has “Buy” rating given on Wednesday, November 2 by Canaccord Genuity. Canaccord Genuity maintained the shares of DXCM in report on Thursday, September 28 with “Buy” rating. The firm earned “Buy” rating on Monday, September 25 by Canaccord Genuity. Wedbush maintained the stock with “Buy” rating in Thursday, September 28 report. Stephens maintained the shares of DXCM in report on Wednesday, August 2 with “Buy” rating. Barclays Capital maintained the stock with “Equal-Weight” rating in Thursday, November 2 report. As per Thursday, September 28, the company rating was downgraded by JP Morgan. Cowen & Co maintained it with “Buy” rating and $70.0 target in Wednesday, December 20 report.

DexCom, Inc., a medical device company, together with its subsidiaries, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. The company has market cap of $4.84 billion. The firm offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. It currently has negative earnings. The Company’s products include DexCom G4 PLATINUM system for continuous use by adults with diabetes; DexCom G4 PLATINUM with Share, a remote monitoring system; and DexCom G5 Mobile, a CGM system that directly communicates to a patient's mobile and its data can be integrated with DexCom CLARITY, which is a next generation cloud reporting software for personalized, easy-to-understand analysis of trends to improve diabetes management.

Fossil Group, Inc., together with its subsidiaries, designs, develops, markets, and distributes consumer fashion accessories. The company has market cap of $823.52 million. The companyÂ’s principal products include a line of men's and women's fashion watches and jewelry, handbags, small leather goods, belts, sunglasses, and soft accessories. It currently has negative earnings. It offers its products under its proprietary brands, such as FOSSIL, MICHELE, MISFIT, RELIC, SKAGEN, and ZODIAC, as well as under the licensed brands, including ADIDAS, ARMANI EXCHANGE, BURBERRY, CHAPS, DIESEL, DKNY, EMPORIO ARMANI, KARL LAGERFELD, KATE SPADE NEW YORK, MARC JACOBS, MICHAEL KORS, and TORY BURCH.

Investors sentiment decreased to 1.22 in 2017 Q3. Its down 0.62, from 1.84 in 2017Q2. It worsened, as 36 investors sold Fossil Group, Inc. shares while 33 reduced holdings. 21 funds opened positions while 63 raised stakes. 44.08 million shares or 13.27% less from 50.82 million shares in 2017Q2 were reported. California-based California State Teachers Retirement Systems has invested 0% in Fossil Group, Inc. (NASDAQ:FOSL). Cap Fund Mngmt Sa reported 13,303 shares. Jacobs Levy Equity accumulated 119,700 shares or 0.02% of the stock. 31 are owned by Parkside Bank & Trust Tru. Moreover, State Board Of Administration Of Florida Retirement has 0% invested in Fossil Group, Inc. (NASDAQ:FOSL). Contrarius Inv Mgmt Limited has invested 0.61% in Fossil Group, Inc. (NASDAQ:FOSL). The Georgia-based Synovus Corporation has invested 0.01% in Fossil Group, Inc. (NASDAQ:FOSL). Rhumbline Advisers owns 0% invested in Fossil Group, Inc. (NASDAQ:FOSL) for 90,531 shares. Southpoint Advisors L P stated it has 2.15M shares. Aperio Grp has 0% invested in Fossil Group, Inc. (NASDAQ:FOSL) for 21,244 shares. Parametric Port Assocs Ltd invested 0% of its portfolio in Fossil Group, Inc. (NASDAQ:FOSL). Sg Americas Securities Limited Liability Corporation has invested 0.02% in Fossil Group, Inc. (NASDAQ:FOSL). Susquehanna Int Grp Ltd Liability Partnership stated it has 0% in Fossil Group, Inc. (NASDAQ:FOSL). State Common Retirement Fund holds 0% in Fossil Group, Inc. (NASDAQ:FOSL) or 43,400 shares. Systematic Limited Partnership, New Jersey-based fund reported 155,305 shares.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>